Tell Congress: Save CBD Oil!

Over the last couple of years, ANH has been reporting on the many benefits of CBD oil, a non-psychoactive compound found in the hemp plant. Among other things, CBD oil is extremely helpful in managing pain. You might think that, in the midst of a crippling epidemic of opioid addiction, a public health agency would be interested in preserving access to affordable, non-addictive pain remedies. But the FDA could shut the door permanently on consumer access to affordable CBD oil, unless concerned citizens make their voices heard.

Write to your elected officials and ask them to support legislation to protect CBD oil and hemp oils.

Recipients

Your Senators
Your Representative

Contact

*Required fields

* Title:

* First Name:

* Last Name:

* Your Email:

* Address 1:

Address 2:

* City:

* State / Province:

* ZIP / Postal Code:

* Phone Number:

Yes, I would like to receive periodic updates and communications from Alliance for Natural Health USA.

Remember me. What's this?

Message

Please support HR 5587

Dear [Decision Maker],

* Personalize your message

For years, consumers have benefitted from access to cheap, safe, and effective CBD oil supplements. But now the FDA says that CBD is a drug, not a supplement--a drug which will be sold for $32,500 a year. Legally the FDA could at any time remove all CBD supplements--and potentially full spectrum hemp oils--from the market, on its own volition, or if the drug company who holds drug market exclusivity requests FDA do so. Please support HR 5587, which will amend the definition of a dietary supplement to allow CBD supplements to be sold despite the existence of a drug.

This is happening because of a back-channel that allows natural supplements to be turned into drugs by the FDA. It works like this: if a company is investigating a substance as a drug, FDA rules give the company market exclusivity on that substance--even if it is currently being sold as a supplement. There are only a few exceptions to this rule.

This means that, at any time, GW Pharmaceuticals, the manufacturer of the CBD drug, can ask the FDA to remove cheap CBD oil supplements from the market, and the only option consumers will have is their new drug that costs $32,500 a year. This hasn't happened yet, but we think GW is simply waiting for the market for CBD oil to grow--which it is. When it reaches a tipping point, then GW can ask the FDA to remove all the CBD supplements, and wait for the cash to roll in from consumers who don't have any other choice.

This threat to affordable CBD oil shows how broken this system is. An opioid epidemic is ravaging our country, with drug overdose deaths surpassing car accident fatalities. People are addicted to and dying from FDA-approved drugs, yet the agency is poised to eliminate consumer access to a non-addictive, cheap, safe, and effective alternative in CBD oil--all so one drug company can charge tens of thousands of dollars for what currently costs a few dollars.

Please support HR 5587 and protect CBD oil supplements and full spectrum hemp oils!

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]